Clinical Trials Directory

Trials / Completed

CompletedNCT01659398

Enhanced External Counterpulsation and Its Effects on Vascular Hemodynamics in Cognitively Impaired Patients

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Patrick Moriarty, MD, FACP, FACC · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate whether enhanced external counterpulsation (EECP) therapy for 7 consecutive weeks will improve cerebral blood flow and possibly over time enhance or slow down breakdown of cognitive function in patients diagnosed with mild cognitive impairment (MCI).

Conditions

Interventions

TypeNameDescription
DEVICEExternal Counterpulsation (EECP)A noninvasive neuroimaging technique. Administration of 35 hours EECP therapy over a 7 week period. EECP to be administered for 1 hour, 5 times a week.

Timeline

Start date
2012-06-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2012-08-07
Last updated
2016-01-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01659398. Inclusion in this directory is not an endorsement.